Honasa Consumer shares surged after the company outlined a revenue target of ₹5,500 crore by FY31. The guidance implies an annual growth rate of around 18% between FY26 and FY31. Growth is expected to be led by Mamaearth, with revenue projected to exceed ₹2,000 crore, while The Derma Co is expected to contribute nearly ₹1,500 crore by FY31.
Honasa shares jump 6% on Rs 5,500 crore revenue target by FY31. What is Goldman Sachs saying?
Honasa Consumer shares surged after the company outlined a revenue target of ₹5,500 crore by FY31. The guidance implies an annual growth rate of around 18%…
Lok Darpan
